Aceto-whitening in the Assessment of Gastrointestinal Neoplasia
Acetowhitening Time as a Novel Objective Tool for the Diagnosis of High Risk Neoplasia in Barrett's Oesophagus
Sponsor: Portsmouth Hospitals NHS Trust
Listed as NCT01618643, this observational or N/A phase trial focuses on Barrett Adenocarcinoma and Barrett Esophagus and remains completed. Sponsored by Portsmouth Hospitals NHS Trust, it has been updated 11 times since 2010, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
11 versions recorded-
Jan 2026 — Present [monthly]
Completed
Status: Unknown → Completed
-
Sep 2024 — Jan 2026 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
▶ Show 6 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
-
Jun 2018 — Nov 2020 [monthly]
Unknown Status
-
May 2018 — Jun 2018 [monthly]
Unknown Status
-
Apr 2018 — May 2018 [monthly]
Unknown Status
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Unknown Status NA
-
Jan 2017 — Aug 2017 [monthly]
Unknown Status NA
First recorded
Nov 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Portsmouth Hospitals NHS Trust
- University of Portsmouth
For direct contact, visit the study record on ClinicalTrials.gov .